{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:29:07Z","timestamp":1794522547265,"version":"4.9.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017695","name":"Health Commission of Hunan Province","doi-asserted-by":"publisher","award":["Z2023100"],"award-info":[{"award-number":["Z2023100"]}],"id":[{"id":"10.13039\/100017695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017695","name":"Health Commission of Hunan Province","doi-asserted-by":"publisher","award":["20254200"],"award-info":[{"award-number":["20254200"]}],"id":[{"id":"10.13039\/100017695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025JJ40100"],"award-info":[{"award-number":["2025JJ40100"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024JJ6728"],"award-info":[{"award-number":["2024JJ6728"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ijbiomac.2025.147332","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T06:35:48Z","timestamp":1756794948000},"page":"147332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"P1","title":["Delactylation of H3K9 by Sirtuin6 inhibits MGMT transcription and reverses temozolomide resistance in glioblastoma"],"prefix":"10.1016","volume":"327","author":[{"given":"Li","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Botao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenliang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijbiomac.2025.147332_bb0005","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-oncology"},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.147332_bb0010","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and other malignant gliomas: a clinical review","volume":"310","author":"Omuro","year":"2013","journal-title":"Jama"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.147332_bb0015","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70042","article-title":"Autoimmune astrocytopathy double negative for AQP4-IgG and GFAP-IgG: retrospective research of clinical practice, biomarkers, and pathology","volume":"30","author":"Lin","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.147332_bb0020","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jama.2023.0023","article-title":"Glioblastoma and other primary brain malignancies in adults: a review","volume":"329","author":"Schaff","year":"2023","journal-title":"Jama"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.147332_bb0025","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147332_bb0030","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.trecan.2025.01.007","article-title":"Regulated cell death modalities: breaking resistance of temozolomide glioblastoma therapy","volume":"11","author":"Mishchenko","year":"2025","journal-title":"Trends in cancer"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.147332_bb0035","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1470-2045(01)00489-2","article-title":"Current and future developments in the use of temozolomide for the treatment of brain tumours","volume":"2","author":"Stupp","year":"2001","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147332_bb0040","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s42003-024-06488-9","article-title":"Integrative analysis of genomic and epigenomic regulation reveals miRNA mediated tumor heterogeneity and immune evasion in lower grade glioma","volume":"7","author":"Yang","year":"2024","journal-title":"Communications biology"},{"issue":"Pt 1","key":"10.1016\/j.ijbiomac.2025.147332_bb0045","article-title":"TMEM64 aggravates the malignant phenotype of glioma by activating the Wnt\/\u03b2-catenin signaling pathway","volume":"260","author":"Yang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.147332_bb0050","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.7150\/thno.82005","article-title":"Current advances in temozolomide encapsulation for the enhancement of glioblastoma treatment","volume":"13","author":"Iturrioz-Rodr\u00edguez","year":"2023","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147332_bb0055","first-page":"17","article-title":"Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review","volume":"4","author":"Singh","year":"2021","journal-title":"Cancer Drug Resistance (Alhambra, Calif.)"},{"key":"10.1016\/j.ijbiomac.2025.147332_bb0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0079-6603(08)60879-X","article-title":"Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase","volume":"51","author":"Pegg","year":"1995","journal-title":"Prog. Nucleic Acid Res. Mol. Biol"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147332_bb0065","doi-asserted-by":"crossref","first-page":"345","DOI":"10.32604\/or.2023.028724","article-title":"Mechanism of NURP1 in temozolomide resistance in hypoxia-treated glioma cells via the KDM3A\/TFEB axis","volume":"31","author":"Li","year":"2023","journal-title":"Oncol. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.147332_bb0070","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/neuonc\/noab003","article-title":"PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma","volume":"23","author":"Wu","year":"2021","journal-title":"Neuro-oncology"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147332_bb0075","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/neuonc\/noac242","article-title":"A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair\/MGMT in glioblastoma","volume":"25","author":"Zhao","year":"2023","journal-title":"Neuro-oncology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147332_bb0080","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","article-title":"Temozolomide resistance in glioblastoma multiforme","volume":"3","author":"Lee","year":"2016","journal-title":"Genes & diseases"},{"key":"10.1016\/j.ijbiomac.2025.147332_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109772","article-title":"Temozolomide-based sonodynamic therapy induces immunogenic cell death in glioma","volume":"256","author":"Zhou","year":"2023","journal-title":"Clinical immunology (Orlando, Fla.)"},{"issue":"18","key":"10.1016\/j.ijbiomac.2025.147332_bb0090","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1007\/s00018-010-0402-y","article-title":"Protein deacetylation by sirtuins: delineating a post-translational regulatory program responsive to nutrient and redox stressors","volume":"67","author":"Bao","year":"2010","journal-title":"Cellular and molecular life sciences\u202f: CMLS"},{"key":"10.1016\/j.ijbiomac.2025.147332_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101936","article-title":"Sirtuins, resveratrol and the intertwining cellular pathways connecting them","volume":"88","author":"Ungurianu","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"5\u20136","key":"10.1016\/j.ijbiomac.2025.147332_bb0100","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cbpa.2012.10.003","article-title":"Sirtuins: NAD(+)-dependent deacetylase mechanism and regulation","volume":"16","author":"Sauve","year":"2012","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2025.147332_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.arr.2017.08.001","article-title":"Sirtuins, epigenetics and longevity","volume":"40","author":"W\u0105troba","year":"2017","journal-title":"Ageing Res. Rev."},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.147332_bb0110","doi-asserted-by":"crossref","first-page":"6726","DOI":"10.7150\/thno.100667","article-title":"Targeting sirtuins for cancer therapy: epigenetics modifications and beyond","volume":"14","author":"Shen","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2025.147332_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104880","article-title":"Emerging role of sirtuins in breast cancer metastasis and multidrug resistance: implication for novel therapeutic strategies targeting sirtuins","volume":"158","author":"Sinha","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijbiomac.2025.147332_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101054","article-title":"Inhibition of SIRT7 overcomes sorafenib acquired resistance by suppressing ERK1\/2 phosphorylation via the DDX3X-mediated NLRP3 inflammasome in hepatocellular carcinoma","volume":"73","author":"Kim","year":"2024","journal-title":"Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147332_bb0125","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1038\/s41467-021-26180-4","article-title":"DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147332_bb0130","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.molcel.2017.04.026","article-title":"Nucleus-translocated ACSS2 promotes gene transcription for lysosomal biogenesis and autophagy","volume":"66","author":"Li","year":"2017","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147332_bb0135","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ijc.34381","article-title":"Epigenetic alterations in glioblastomas: diagnostic, prognostic and therapeutic relevance","volume":"153","author":"Montella","year":"2023","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147332_bb0140","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2008.10.052","article-title":"SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span","volume":"136","author":"Kawahara","year":"2009","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147332_bb0145","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nsmb.3202","article-title":"SIRT6 deacetylates H3K18ac at pericentric chromatin to prevent mitotic errors and cellular senescence","volume":"23","author":"Tasselli","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"43","key":"10.1016\/j.ijbiomac.2025.147332_bb0150","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409132121","article-title":"Lactylation of RNA m(6)a demethylase ALKBH5 promotes innate immune response to DNA herpesviruses and mpox virus","volume":"121","author":"Li","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.147332_bb0155","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1056\/NEJMe058010","article-title":"Chemotherapy for brain tumors--a new beginning","volume":"352","author":"DeAngelis","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147332_bb0160","article-title":"Clinical value of the MGMT promoter methylation score in IDHmt low-grade glioma for predicting benefit from temozolomide treatment","volume":"7","author":"Darlix","year":"2025","journal-title":"Neuro-Oncol. Adv."},{"key":"10.1016\/j.ijbiomac.2025.147332_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217471","article-title":"Aggressive resection of non-contrast-enhanced tumor provides varying benefits to glioblastoma, IDH-wildtype patients based on different clinical characteristics","volume":"612","author":"Liu","year":"2025","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147332_bb0170","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s11060-025-04952-y","article-title":"Treatment practices and survival outcomes for IDH-wildtype glioblastoma patients according to MGMT promoter methylation status: insights from the U.S. National Cancer Database","volume":"172","author":"Pham","year":"2025","journal-title":"J. Neuro-Oncol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.147332_bb0175","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1158\/0008-5472.CAN-24-3173","article-title":"Cancer-associated fibroblasts foster a high-lactate microenvironment to drive perineural invasion in pancreatic cancer","volume":"85","author":"Li","year":"2025","journal-title":"Cancer Res."},{"issue":"22","key":"10.1016\/j.ijbiomac.2025.147332_bb0180","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176851","article-title":"Lactate reprograms glioblastoma immunity through CBX3-regulated histone lactylation","volume":"134","author":"Wang","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147332_bb0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12964-025-02139-6","article-title":"Immunomodulatory effects of tumor lactate dehydrogenase C (LDHC) in breast cancer","volume":"23","author":"Naik","year":"2025","journal-title":"Cell communication and signaling\u202f: CCS"},{"key":"10.1016\/j.ijbiomac.2025.147332_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2024.111045","article-title":"Simvastatin alleviates glymphatic system damage via the VEGF-C\/VEGFR3\/PI3K-Akt pathway after experimental intracerebral hemorrhage","volume":"216","author":"Liao","year":"2024","journal-title":"Brain Res. Bull."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.147332_bb0195","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1007\/s12035-023-03911-w","article-title":"M(6)A-mediated upregulation of lncRNA CHASERR promotes the progression of glioma by modulating the miR-6893-3p\/TRIM14 Axis","volume":"61","author":"Wu","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.147332_bb0200","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14489","article-title":"A TGF-\u03b2 signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response","volume":"30","author":"Duan","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.147332_bb0205","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/1568009623666230817102104","article-title":"Mirna-383-5p functions as an anti-oncogene in glioma through the Akt\/mTOR signaling pathway by targeting VEGFA","volume":"24","author":"Liu","year":"2024","journal-title":"Curr. Cancer Drug Targets"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.147332_bb0210","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1021\/jacs.2c13512","article-title":"Structural basis of Sirtuin 6-catalyzed nucleosome deacetylation","volume":"145","author":"Wang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147332_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e41440","article-title":"Bullatine a suppresses glioma cell growth by targeting SIRT6","volume":"11","author":"Wang","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.ijbiomac.2025.147332_bb0220","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cellsig.2019.04.009","article-title":"Transcriptional activation of SIRT6 via FKHRL1\/FOXO3a inhibits the Warburg effect in glioblastoma cells","volume":"60","author":"Dong","year":"2019","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.147332_bb0225","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41401-021-00679-4","article-title":"Role of TRPM2 in brain tumours and potential as a drug target","volume":"43","author":"Ji","year":"2022","journal-title":"Acta Pharmacol. Sin."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025078894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025078894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T20:24:33Z","timestamp":1760559873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025078894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":45,"alternative-id":["S0141813025078894"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.147332","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delactylation of H3K9 by Sirtuin6 inhibits MGMT transcription and reverses temozolomide resistance in glioblastoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.147332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"147332"}}